RxDoctor Payments Data

Gerald Park, MD

Urology · North Kansas City, MONPI 1841241387

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $95,161 of the $135,956 with a category attached, or 70.0%. Procept Biorobotics Corporation accounts for 77.4% of it on its own, with 55 other manufacturers making up the rest. 2025 is the largest year on record at $76,489, 8.3 times the $9,226 reported in 2019. Among urology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$135,956in general payments, 2019–2025

Across 514 payments — averaging $264.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Procept Biorobotics Corporation$105K
  • Intuitive Surgical$13K
  • Teleflex LLC$7K
  • Medtronic$1K
  • Histosonics, Inc.$1K
  • Conmed Corporation$1K
  • plus $6K from 50 others

What the payments were for

  • Consulting fees$95,16170%
  • Speaking & faculty fees$3,2252%
  • Travel & lodging$16,36312%
  • Food & beverage$17,24613%
  • Education$3,9233%
  • Gifts$380%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$135,956 in reported general payments places this provider in the 95th percentile of 250 urology providers in Missouri.

See all urology providers in Missouri

Medicare billing

Part B allowed, 2024
$358,322
Medicare patients
701
Services billed
6,160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron91$54,798
MyrbetriqMirabegron72$42,873
Dutasteride322$9,091
Tamsulosin Hcl426$4,130
Estradiol25$2,361
Trospium Chloride43$2,225
Finasteride103$1,266
Bethanechol Chloride22$748
Oxybutynin Chloride ErOxybutynin Chloride29$721
Alfuzosin Hcl ErAlfuzosin Hcl16$333
Ciprofloxacin Hcl51$241
Cephalexin24$180
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen35$154
Allopurinol12$153
Bicalutamide12$100

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$202$54,79891 claims
Astellas Pharma US IncMyrbetriq$895$42,87372 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 250 urology providers in Missouri.

Other urology in North Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →